Background
pancreatic tumors
PANCREATIC TUMORS
Academic Editor: Hu Wang Nimotuzumab exerts its antitumor effect (mainly antiproliferative, proapoptotic, and antiangiogenic) by blocking the epidermal growth factor receptor overexpressing between 30 and 95% in pancreatic tumors cells. 